Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study.

Auteurs

de Angelis M, Pellegrino F, Scilipoti P, Longoni M, Santangelo A, Subiela JD, Contieri R, Afferi L, Zamboni S, Suardi N, Musi G, Luzzago S, D'Andrea D, Laukhtina E, Soria F, Gontero P, Del Giudice F, Khan MS, Thurairaja R, Roupret M, Grobet-Jeandin E, Baudewyns A, Tanaka H, Matsumoto S, Fujii Y, Proietti F, Simone G, Schulz GB, Pyrgidis N, Ploussard G, Antonelli A, Bertolo R, Roumiguie M, Bajeot AS, Mir MC, Umari P, Teoh J, Wong C, Mertens LS, Pichler R, Mori K, Ślusarczyk A, Poyet C, Albisinni S, Aziz A, Volpe A, Shariat S, Pradere B, Karakiewicz P, Resca S, Beatrici E, De Groote R, Mottrie A, Necchi A, Montorsi F, Briganti A, Moschini M

  • Date de publication

    Octobre 2025
  • Type

    Article
  • Revue

    World J Urol
  • Nom du chercheur

    BAUDEWYNS ARTHUR
  • Hôpital

    Institut Jules Bordet
  • Service

    Urologie
  • PMID

    41148346
  • DOI

    10.1007/s00345-025-05992-9